Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
Clinical trial NCT05192122 · RECRUITING
Trial details
- NCT number
- NCT05192122
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2029-01-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.